A phase II study of high-dose celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma - PubMed - 0 views
-
Nathan Goodyear on 09 Sep 21Oral metronomic chemotherapy with celebrex shown to provide appx 50% stable NHL disease in refractory NHL.